- Home
- LUNG vs RCS Comparison
LUNG vs RCS Comparison
Compare LUNG & RCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNG
- RCS
- Stock Information
- Founded
- LUNG 1995
- RCS 1994
- Country
- LUNG United States
- RCS United States
- Employees
- LUNG N/A
- RCS N/A
- Industry
- LUNG Industrial Specialties
- RCS Investment Managers
- Sector
- LUNG Health Care
- RCS Finance
- Exchange
- LUNG Nasdaq
- RCS Nasdaq
- Market Cap
- LUNG 299.3M
- RCS 292.8M
- IPO Year
- LUNG 2020
- RCS N/A
- Fundamental
- Price
- LUNG $7.77
- RCS $6.27
- Analyst Decision
- LUNG Strong Buy
- RCS
- Analyst Count
- LUNG 7
- RCS 0
- Target Price
- LUNG $12.64
- RCS N/A
- AVG Volume (30 Days)
- LUNG 464.2K
- RCS 141.1K
- Earning Date
- LUNG 04-30-2025
- RCS 01-01-0001
- Dividend Yield
- LUNG N/A
- RCS 10.12%
- EPS Growth
- LUNG N/A
- RCS N/A
- EPS
- LUNG N/A
- RCS N/A
- Revenue
- LUNG $83,789,000.00
- RCS N/A
- Revenue This Year
- LUNG $17.96
- RCS N/A
- Revenue Next Year
- LUNG $18.35
- RCS N/A
- P/E Ratio
- LUNG N/A
- RCS N/A
- Revenue Growth
- LUNG 22.01
- RCS N/A
- 52 Week Low
- LUNG $5.46
- RCS $4.51
- 52 Week High
- LUNG $10.01
- RCS $6.31
- Technical
- Relative Strength Index (RSI)
- LUNG 52.56
- RCS 45.23
- Support Level
- LUNG $7.65
- RCS $6.22
- Resistance Level
- LUNG $8.12
- RCS $6.38
- Average True Range (ATR)
- LUNG 0.49
- RCS 0.11
- MACD
- LUNG -0.06
- RCS 0.01
- Stochastic Oscillator
- LUNG 45.71
- RCS 17.74
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
About RCS PIMCO Strategic Income Fund Inc.
PIMCO Strategic Income Fund, Inc. operates as a closed-end management investment company. Its primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities. The Fund also seeks capital appreciation to the extent consistent with this objective.